Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cisplatin and Irinotecan in Suboptimally Debulked Ovarian Cancer
NCT00003345Phase 2Completed
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- Oct 1997
- Primary completion
- Oct 2001
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of irinotecan in ovarian cancer, fallopian tube cancer (PFTC), primary peritoneal cancer (PPC), sponsored by Memorial Sloan Kettering Cancer Center. Started Oct 1997; status: completed.
02
Drugs
irinotecan
03
Conditions
ovarian cancerfallopian tube cancer (PFTC)primary peritoneal cancer (PPC)
Beyond the preview
Go deeper on NCT00003345.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003345.